{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T23:37:47Z","timestamp":1649201867840},"reference-count":61,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.medcli.2010.04.016","type":"journal-article","created":{"date-parts":[[2010,6,30]],"date-time":"2010-06-30T09:15:39Z","timestamp":1277889339000},"page":"221-229","source":"Crossref","is-referenced-by-count":2,"title":["De la citogen\u00e9tica convencional al an\u00e1lisis por micromatrices. Cincuenta a\u00f1os del cromosoma Filadelfia"],"prefix":"10.1016","volume":"137","author":[{"given":"Jes\u00fas M.","family":"Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Granada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Sol\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2010.04.016_bib1","first-page":"85","article-title":"Chromosome studies on normal and leukemia human leukocytes","volume":"25","author":"Nowell","year":"1960","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.medcli.2010.04.016_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood.V35.1.23.23","article-title":"Identification of the Philadelphia (Ph-1) chromosome","volume":"35","author":"Prieto","year":"1970","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2010.04.016_bib3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"A new consistent chromosomal abnormality to chronic meylogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.medcli.2010.04.016_bib4","series-title":"Chromosomes in human cancer and leukemia","author":"Sandberg","year":"1990"},{"key":"10.1016\/j.medcli.2010.04.016_bib5","series-title":"WHO classification of tumor of haematopoietic and lymphoid tissues","year":"2008"},{"key":"10.1016\/j.medcli.2010.04.016_bib6","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nrg1692","article-title":"The new cytogenetics: Blurring the boundaries with molecular biology","volume":"6","author":"Speicher","year":"2005","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.medcli.2010.04.016_bib7","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/sj.leu.2402605","article-title":"Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype","volume":"16","author":"Cuneo","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.medcli.2010.04.016_bib8","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1038\/sj.leu.2402293","article-title":"Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype","volume":"15","author":"Rigolin","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.medcli.2010.04.016_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s004390050604","article-title":"A novel source of highly specific chromosome painting probes for human karyotype analysis derived from primate homologues","volume":"101","author":"Muller","year":"1997","journal-title":"Hum Genet"},{"key":"10.1016\/j.medcli.2010.04.016_bib10","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0002-9440(10)64140-5","article-title":"Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics","volume":"158","author":"Hern\u00e1ndez","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.medcli.2010.04.016_bib11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1126\/science.286.5439.531","article-title":"Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring","volume":"286","author":"Golub","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.medcli.2010.04.016_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.medcli.2010.04.016_bib13","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1182\/blood-2004-01-0274","article-title":"Genomic approaches to hematologic malignancies","volume":"104","author":"Ebert","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2010.04.016_bib14","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2007-05-092304","article-title":"Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS\/MPD, and MDS-derived AML","volume":"111","author":"Gondek","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2010.04.016_bib15","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1182\/blood-2009-02-205690","article-title":"Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic\/myeloproliferative neoplasms","volume":"113","author":"Jankowska","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2010.04.016_bib16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2141.2009.07757.x","article-title":"Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies","volume":"146","author":"Maciejewski","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.medcli.2010.04.016_bib17","unstructured":"Mitelman F, Johansson B, Mertens F, editores. Mitelman database of chromosome aberrations in cancer.[consultado 31\/3\/2010]. Disponible en: http:\/\/cgap.nci.nih.gov\/Chromosomes\/Mitelman"},{"key":"10.1016\/j.medcli.2010.04.016_bib18","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.leukres.2005.12.025","article-title":"Geographic differences in the incidence of cytogenetic abnormalities of acute myelogenous leukemia (AML) in Spain","volume":"30","author":"Sierra","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.medcli.2010.04.016_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0268-960X(03)00040-7","article-title":"Cytogenetics in acute leukemia","volume":"18","author":"Mr\u00f3zek","year":"2004","journal-title":"Blood Reviews"},{"key":"10.1016\/j.medcli.2010.04.016_bib20","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0165-4608(84)80022-9","article-title":"Fourth International Workshop on Chromosomes in leukemia, 1982: Clinical significance of chromosomal abnormalities in acute nonlymphoblastic leukemia","volume":"11","author":"Bloomfield","year":"1984","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.medcli.2010.04.016_bib21","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial","volume":"92","author":"Grimwade","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2010.04.016_bib22","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1182\/blood.V96.13.4075","article-title":"Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group\/Eastern Cooperative Oncology Group Study","volume":"96","author":"Slovak","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2010.04.016_bib23","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","article-title":"Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: Results from Cancer and Leukemia Group B (CALGB 8461)","volume":"100","author":"Byrd","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2010.04.016_bib24","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa040465","article-title":"Prognostically useful gene-expression profiles in acute myeloid leukemia","volume":"350","author":"Valk","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2010.04.016_bib25","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMoa031046","article-title":"Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia","volume":"350","author":"Bullinger","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2010.04.016_bib26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/sj.leu.2403625","article-title":"Gene expression profile reveals deregulation of genes with relevant functions in the different subclasses of acute myeloid leukemia","volume":"19","author":"Guti\u00e9rrez","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.medcli.2010.04.016_bib27","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1200\/JCO.2009.21.9840","article-title":"New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia","volume":"27","author":"Tiu","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.medcli.2010.04.016_bib28","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European LeukemiaNet","volume":"115","author":"D\u00f6hner","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2010.04.016_bib29","first-page":"868","article-title":"Chromosomal abnormalities and their clinical significance in acute lymphoblastic leukemia","volume":"43","year":"1983","journal-title":"Cancer Res"},{"key":"10.1016\/j.medcli.2010.04.016_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cancergencyto.2005.02.019","article-title":"Genetic abnormalities associated with the t(12;21) and their impact in the outcome of 56 patients with B-precursor acute lymphoblastic leukemia","volume":"162","author":"\u00c1lvarez","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.medcli.2010.04.016_bib31","first-page":"1094","article-title":"TEL\/AML1 gene fusion is related to in vitro drug sensitivity for L asparaginasa in childhood acute lymphoblastic leukemia","volume":"96","author":"Ramakers-van Woerden","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2010.04.016_bib32","first-page":"196","article-title":"Philadelphia positive acute lymphoblastic leukemia in adults: Age distribution, BCR breakpoint and prognosis significance","volume":"5","author":"Secker-Walker","year":"1991","journal-title":"Leukemia"},{"key":"10.1016\/j.medcli.2010.04.016_bib33","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1046\/j.1365-2141.1996.d01-1968.x","article-title":"Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemia","volume":"95","author":"Rieder","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.medcli.2010.04.016_bib34","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood-2006-10-051912","article-title":"Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): Analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 trial","volume":"109","author":"Moorman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2010.04.016_bib35","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2141.2004.04948.x","article-title":"Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia","volume":"125","author":"Harrison","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.medcli.2010.04.016_bib36","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1182\/blood-2003-04-1299","article-title":"A report from the LALA-94 and LALA-SA groups on hypodiploidy with 30 to 39 chromosomes and near-triploidy: 2 possible expressions of a sole entity conferring poor prognosis in adult acute lymphoblastic leukemia (ALL)","volume":"104","author":"Charrin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2010.04.016_bib37","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1182\/blood.V91.9.3357","article-title":"Highly sensitive fluorescence in situ hybridization method to detect double BCR\/ABL fusion and monitor response to therapy in chronic myeloid leukemia","volume":"91","author":"Dewald","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2010.04.016_bib38","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"348","author":"O\u2019Brien","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2010.04.016_bib39","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1023\/A:1008393002748","article-title":"Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia","volume":"11","author":"Hern\u00e1ndez","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.medcli.2010.04.016_bib40","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2010.04.016_bib41","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1365-2141.2000.01868.x","article-title":"Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes","volume":"108","author":"Sol\u00e9","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.medcli.2010.04.016_bib42","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/251437a0","article-title":"Distinct haematological disorder with deletion of long arm of n.o 5 chromosome","volume":"251","author":"Van den Berghe","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.medcli.2010.04.016_bib43","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1182\/blood-2007-03-082404","article-title":"New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: Evidence from a core dataset of 2124 patients","volume":"110","author":"Haase","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2010.04.016_bib44","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2010.04.016_bib45","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","article-title":"Mutation in TET2 in myeloid cancers","volume":"360","author":"Delhommeau","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2010.04.016_bib46","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"D\u00f6hner","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2010.04.016_bib47","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3324\/haematol.13862","article-title":"A high number of losses in 13q14 chromosome band is associated with a worse outcome and biological differences in patients with B-cell chronic lymphoid leukemia","volume":"94","author":"Hern\u00e1ndez","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.medcli.2010.04.016_bib48","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1182\/blood.V100.4.1177.h81602001177_1177_1184","article-title":"Multivariate analysis of prognostic factors in CLL: Clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors","volume":"100","author":"Oscier","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2010.04.016_bib49","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1182\/blood.V86.11.4250.bloodjournal86114250","article-title":"Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities","volume":"86","author":"Tricot","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2010.04.016_bib50","first-page":"1146","article-title":"Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: Monosomy of chromosome 13 and structural abnormalities of 11q are associated with high percentage of S-phase plasma cells","volume":"85","author":"Guti\u00e9rrez","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.medcli.2010.04.016_bib51","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1182\/blood-2004-04-1319","article-title":"Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma","volume":"104","author":"Guti\u00e9rrez","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2010.04.016_bib52","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma","volume":"349","author":"Tian","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2010.04.016_bib53","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/sj.leu.2402116","article-title":"Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic hybridization","volume":"15","author":"Guti\u00e9rrez","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.medcli.2010.04.016_bib54","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2010.04.016_bib55","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1002\/cncr.24430","article-title":"Array CGH identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas","volume":"115","author":"Robledo","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.medcli.2010.04.016_bib56","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1038\/sj.leu.2403080","article-title":"Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt lymphoma. A cytogenetic and comparative genomic hybridization study","volume":"17","author":"Garc\u00eda","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.medcli.2010.04.016_bib57","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt's lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2010.04.016_bib58","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":"A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling","volume":"354","author":"Greiner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2010.04.016_bib59","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1182\/blood.V93.11.3601","article-title":"The apoptosis inhibitor gene API2 and a novel gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with MALT lymphomas","volume":"93","author":"Dierlamm","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2010.04.016_bib60","first-page":"71","article-title":"Splenic marginal zone B-cell lymphomas: Two cytogentic subtypes, one with gain of 3q and the other with loss of 7q","volume":"86","author":"Sol\u00e9","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.medcli.2010.04.016_bib61","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1182\/blood.V92.5.1735","article-title":"Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myelproliferative syndrome","volume":"92","author":"Reiter","year":"1998","journal-title":"Blood"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775310005804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775310005804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T08:00:18Z","timestamp":1591430418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775310005804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0025775310005804"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2010.04.016","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}